Page results
-
How to access your video appointment using MyCare UCLH with Microsoft Teams patient information page.
-
Organisations and services offering financial advice to people affected by cancer and blood conditions, and their familes and carers.
-
Information on the different ways you can travel to University College London Hospitals (UCLH) if you don’t qualify for patient transport. It also includes advice on financial support that may be available to you.
-
Muscle weakness can be common after major surgery or a long stay in hospital. Resistance exercises improve strength and endurance, helping a faster return to normal activities.
-
Information for visitors including visiting times, limit and infection control in place for each ward and location.
-
A guide to choosing diabetes technology for UCLH patients
-
This page is for patients who are doing a face-to-face breath test in the hospital. Please read it carefully before you arrive for your test.
-
This page explains what you can expect after you have been referred to the Lymphoedema Service at University College London Hospitals (UCLH) for a face-to-face appointment.
-
This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels and ketones when using hybrid closed loop (HCL) systems.
-
This information is for children and young people with Type 1 diabetes, and their families, on how to manage high glucose levels when using an insulin pump.
File results
-
FOI/2022/0499 - Framework/ tender for services used to collect offensive and clinical waste
-
FOI/2022/0505 - Type of needles used for insulin administration to patients
-
FOI/2022/0515 - Senior staff contact details
-
FOI/2022/0536 - Head of Procurement contact details
-
FOI/2022/0551 - Procurement contact details
-
FOI/2022/0555 - Senior staff contact details
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0542 - Infection control audits from September 2020 to April 2021
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology